Abstract
This is the third article in a four-part series on nuclear medicine oncology procedures. Upon completion, the technologist will be able to (1) describe the evolution of iodine-131 ablation, (2) list rationale and indications for its use, and (3) discuss management of the patient before, during, and after treatment.
